fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Pfizer to present new genitourinary cancer research at ASCO GU 2025

Written by | 1 Feb 2025

Pfizer Inc. will present the latest results from its leading genitourinary (GU) portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium taking place February… read more.

Sobi to unveil new data at the annual European Association for Haemophilia and Allied Disorders (EAHAD 2025)

Written by | 28 Jan 2025

Sobi will unveil new data at the annual European Association for Haemophilia and Allied Disorders (EAHAD 2025) congress in Milan from the 4th – 7th February, 2025. Outcomes… read more.

Abivax to present seven abstracts highlighting Obefazimod clinical data at ECCO 2025

Written by | 24 Jan 2025

Abivax SA, a clinical-stage biotechnology company developing innovative therapies to address chronic inflammatory diseases, today announced that seven scientific abstracts on its lead drug candidate, obefazimod, [an investigational,… read more.

United Therapeutics to showcase innovations and insights in pulmonary hypertension at PVRI 2025

Written by | 22 Jan 2025

United Therapeutics Corporation a public benefit corporation, announced that five posters across its commercial and development portfolio in pulmonary hypertension (PH) will be presented at the Pulmonary Vascular… read more.

Agenus Inc to highlights breakthrough findings on Botensilimab and Balstilimab at ASCO GI 2025

Written by | 19 Dec 2024

Agenus Inc. a leader in immuno-oncology, announced five presentations featuring botensilimab (BOT, an Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (BAL, an anti-PD-1 antibody) at the upcoming American Society of… read more.

Intra-Cellular Therapies unveils new data on CAPLYTA at ACNP annual meeting

Written by | 13 Dec 2024

Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, announced presentations at the 63rd Annual Meeting of… read more.

Bayer to present comprehensive findings on Finerenone from FINEARTS-HF trial at CVCT 2024

Written by | 11 Dec 2024

Bayer announced that new analyses from the Phase III FINEARTS-HF trial evaluating finerenone (Kerendia) in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of… read more.

Blueprint Medicines showcases Ayvakit® data highlighting survival benefits and disease-modifying potential in systemic mastocytosis at ASH 2024

Written by | 10 Dec 2024

Blueprint Medicines Corporation (Nasdaq: BPMC) today announced data presentations that continue to demonstrate the long-term clinical benefits of AYVAKIT® (avapritinib) in advanced systemic mastocytosis (advanced SM), and reflect the… read more.

Novo Nordisk to present 13 abstracts at ASH 2024 including phase 2/3 HIBISCUS trial of etavopivat

Written by | 9 Dec 2024

Novo Nordisk announced the presentation of 13 abstracts, three of which will be presented in oral sessions, at the upcoming 66th Annual Meeting and Exposition of the American Society… read more.

New insights on Haemophilia A and rare blood diseases to be presented by Sobi® at ASH 2024

Written by | 5 Dec 2024

New data from Sobi® and partners will be presented at the 66th Annual Meeting of the American Society of Hematology (ASH) in San Diego, CA (USA) from the… read more.

Daiichi Sankyo to present new clinical research across its oncology portfolio at ESMO 2024, ASH 2024 and SABCS 2024

Written by | 4 Dec 2024

Daiichi Sankyo will present new clinical research across its oncology portfolio with more than 45 abstracts in multiple types of solid and blood cancers at the 2024 ESMO… read more.

Roche presents long term outcomes and innovative therapies in hematology at ASH 2024

Written by | 2 Dec 2024

Roche announced  that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held 7-10 December… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.